The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Mortality and Cardiovascular Complications in Older Complex Chronic Patients with Type 2 Diabetes
Open accessAbstract
Aims/Introduction. Determining the prevalence of diabetes and its cardiovascular complications and all-cause mortality in older chronic complex patients. Materials and Methods. We carried out a multicenter retrospective study and included a randomized sample of 932 CCP people. We assessed the prevalence of diabetes according to World Health Organization criteria. Data included demographics and functional, comorbidity, cognitive, and social assessment. Results. The prevalence of diabetes was 53% and average age 81.16±8.93 years. There were no significant differences in the survival of CCP patients with or without DM, with or without ischaemic cardiopathy, and with or without peripheral vascular disease. The prognostic factors of all-cause mortality in patients with DM were age ≥ 80 years [HR 1.47, 95% CI 1.02–2.13, p 0.038], presence of heart failure [HR 1.73, 95% CI 1.25–2.38, p 0.001], Charlson score [HR 1.20, 95% CI 1.06–1.36, p 0.003], presence of cognitive impairment [HR 1.73, 95% CI 1.24–2.40, p 0.001], and no treatment with statins [HR 1.49, 95% CI 1.08–2.04, p 0.038]. Conclusions. We found high prevalence of DM among CCP patients and the relative importance of traditional risk factors seemed to wane with advancing age. Recommendations may include relaxing treatment goals, providing family/patient education, and enhanced communication strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a cohort study of almost 3500 complex chronic patients above the age of 80 of whom 53% had diabetes and a high prevalence of associated classical risk factors, the researchers found that all-cause mortality was more affected by aging factors than by specific complications of diabetes.”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [85]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274 · cited 1×
“5-fold by 2050 [3]; and diabetes is linked to higher mortality, reduced functional status, impaired quality of life, increased risk of institutionalization [4], and mortality.”
BackgroundImpact of Recent Increase in Incidence on Future Diabetes Burden
Narayan, K. M. V., Boyle, J. P., Geiss, L. S., Saaddine, J. B., & Thompson, T. J. (2006) · Diabetes Care · doi:10.2337/dc06-1136 · Cited by 602
Diabetes in Older Adults: A Consensus Report
Sue Kirkman, M., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12035 · Cited by 548 · cited 1×
“A consensus has developed on how to treat older people with diabetes [11, 12], but given that complicationsmay not be present or may take many years to develop, efforts should be adapted depending on the average remaining life expectancy and degree of impairment of quality of life.”
BackgroundHuang, E. S., Laiteerapong, N., Liu, J. Y., John, P. M., Moffet, H. H., & Karter, A. J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12956 · Cited by 501 · cited 1×
“In contrast with other studies [16], our results show that the incidence of all-cause mortality and the prevalence of cardiovascular diseases donot differ significantly amongCCP with and without DM.”
ResultSinclair, A. J., Paolisso, G., Castro, M., Bourdel-Marchasson, I., Gadsby, R., & Rodriguez Mañas, L. (2011) · Diabetes & Metabolism · doi:10.1016/s1262-3636(11)70962-4 · Cited by 298
Mortality in people with Type 2 diabetes in the UK
Mulnier, H. E., Seaman, H. E., Raleigh, V. S., Soedamah‐Muthu, S. S., Colhoun, H. M., & Lawrenson, R. A. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01838.x · Cited by 212
Stokes, A., & Preston, S. H. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170219 · Cited by 166
Charvat, H., Goto, A., Goto, M., Inoue, M., Heianza, Y., Arase, Y., Sone, H., Nakagami, T., Song, X., Qiao, Q., et al. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12333 · Cited by 142 · cited 1×
“The registered prevalence of CCP in our study was higher than in other developed countries [8] as was the prevalence of diabetes mellitus in our CCP population [2, 9, 10].”
ResultDavis, J. W., Chung, R., & Juarez, D. T. (2011) · Europe PMC (PubMed Central) · Cited by 101
Koller, M., Leening, M. J. G., Wolbers, M., Steyerberg, E. W., Hunink, M. G. M., Schoop, R., Hofman, A., Bucher, H. C., Psaty, B. M., Lloyd‐Jones, D. M., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-6-201209180-00002 · Cited by 85
Research works printed but not linked: 4
- 2016, International Journal of Medical Research and Pharmaceutical Sciences, 3
- 2016, Gerontology and Geriatrics Research, 2
- 2016, EC Cardiology, 226
- 2011, Hawaii medical journal, 70, 209
Cited by
Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0728-6 · Cited by 2,312
“[85] suggest that the relative importance of risk factors wanes in complex chronic patients with T2DM with advancing age.”
BackgroundArtime, E., Romera, I., Díaz‐Cerezo, S., & Delgado, E. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01060-8 · Cited by 45
“Clua-Espuny [25] 2013–2016 Local: Terres de l’Ebre health area (Catalonia) Retrospective cohort study Catalonian Health Institute Registry of complex chronic patients 494 Prevalence (CHD, CVA, PAD, HF); mortality”
BackgroundBonikowska, I., Szwamel, K., & Uchmanowicz, I. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168658 · Cited by 37
“It was shown that for people above 80 years of age, the comorbidity of heart failure, the presence of cognitive impairment, and the absence of statin therapy are important predictors of mortality in patients with DM [12].”
BackgroundLong-Term Survival After Stroke According to Reperfusion Therapy, Cardiovascular Therapy and Gender
Clua‐Espuny, J. L., Abilleira, S., Queralt-Tomas, L., González-Henares, A., Gil-Guillén, V. F., Múria-Subirats, E., & Ballesta-Ors, J. (2019) · Cardiology Research · doi:10.14740/cr839 · Cited by 13
“A greater understanding of the differences and similarities between males and females with respect to previous cardiovascular risk factors [1, 17, 18, 20], previous physical or mental condition [21, 22], response to acute stroke therapies, and recovery will hopefully lead to better outcomes in the future.”
BackgroundSelf-citationAlbarakat, M. A., & Guzu, A. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_634_19 · Cited by 16
“[14] Another multicenter retrospective study for 932 chronic DMT2 patients in Spain revealed that ischemic cardiopathy, the peripheral vascular disease did not increase the mortality ratios compared to heart failure and cognitive impairment ratios were higher and seemed to wane with advancing age.[15] Another meta-ana…”
Background
Metadata
- Authors
- Clua-Espuny, J. L., González-Henares, M. A., Queralt-Tomas, M. L. L., Campo-Tamayo, W., Muria-Subirats, E., Panisello-Tafalla, A., & Lucas-Noll, J.
- Affiliations
- Department of Research, ICS Terres de l’Ebre, University Institute in Primary Care Research Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain
- Generalitat de Catalunya (ES)
- Institut Català de la Salut (ES)
- UUDD Tortosa-Terres de l’Ebre, CAP Temple, EAP Tortosa Est, Institut Català de la Salut, 43500 Tortosa, Spain
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-6
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC5569628
- OpenAlex
- W2742927418
- Cited by
- 13
- References
- 13
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 2
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, cc-by-nc-nd)
- Funders
- University Institute in Primary Care Research Jordi Gol
- Topics
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, older adults, complex chronic patients, all-cause mortality, cardiovascular complications, heart failure, peripheral vascular disease, comorbidities, cognitive impairment, statin therapy, Charlson Comorbidity Index, diabetes prevalence
- MeSH terms
- Multiple Chronic Conditions, Aged, Aged, 80 and over, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Heart Failure, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mortality and Cardiovascular Complications in Older Complex Chronic Patients with Type 2 Diabetes. https://app.cochat.ai/papers/10.1155/2017/6078498
- The paper
- Clua-Espuny, J. L., González-Henares, M. A., Queralt-Tomas, M. L. L., Campo-Tamayo, W., Muria-Subirats, E., Panisello-Tafalla, A., & Lucas-Noll, J. (2017). Mortality and Cardiovascular Complications in Older Complex Chronic Patients with Type 2 Diabetes. BioMed Research International. https://doi.org/10.1155/2017/6078498
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.